Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 12 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 11096965

    Compositions and methods related to polycytotoxic T cells

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  2. US 11098283

    T cells modified to overexpress c-Myb

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  3. US 11098053

    Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  4. US 11091516

    Synthetic binder of breast cancer stem cells

    The Board of Regents of the University of Texas System · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  5. US 11077182

    Methods of preparing anti-human papillomavirus antigen T cells

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  6. US 11071755

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  7. US 11072781

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  8. US 11066666

    Bioactive renal cells

    inRegen · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  9. US 11066647

    Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications

    The Regents of the University of California · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  10. US 11059880

    Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  11. US 11052089

    Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype

    The Regents of the University of California · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  12. US 11053484

    Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene

    Precision BioSciences, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  13. US 11053314

    Methods to eliminate cancer stem cells by targeting CD47

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  14. US 11045425

    Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3

    KURARAY CO., LTD. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  15. US 11033620

    Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  16. US 11033621

    Combination therapies targeting tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  17. US 11034933

    Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  18. US 11033587

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  19. US 11034757

    Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  20. US 11028129

    Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions

    The Regents of the University of California · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  21. US 11028369

    Induced extended pluripotent stem cells, method of making and using

    BeiHao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  22. US 11020492

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Therapeutics, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  23. US 11021542

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  24. US 11020495

    Humanized low affinity FCγR mouse cells

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.